Home infusion therapy refers to administering biological drugs in a patient’s home, either by the patient themselves, their family, nurse, or others. Home infusion services include patient training and education, administration, care coordination, pharmacy services, and others. These services and supplies are usually provided by physicians and pharmacy staff, where initially, the patient picks up medications from the physician’s office. Through agencies, nursing services for home care are also provided.
The senior population is the largest consumer of home infusion therapy. As the global population is aging, this population possesses a high risk and susceptibility of this population group to developing chronic conditions that require infusion therapy. Growing demand for home healthcare by the disabled patient group will additionally widen the base for home infusion therapy. Augmenting the use of home infusion therapy also results in a reduction in hospital readmission and in-patient stays, thus containing healthcare costs. Home infusion therapy is also instrumental in reducing the risk of contracting nosocomial infections, thus presenting a potential market penetration opportunity.
The global home infusion therapy market is segmented on the following basis:
Product Category
Pumps for Infusion
Sets IV
Intravenous Cannulas
Type of Therapy
Ant-infectives
Chemotherapy
Hydration Treatment
Pharmaceutical Specialtes
Clinical Nutrition
Consumables and Other Items
Geography
North America a.
US
Canada II
Europe:
UK
Germany II
Europe as a whole
Asia-Pacific
Japan, for example.
China II
the rest of APAC
The Americas
Africa and the Middle East
Key players identified for the healthcare analytical testing market include but are not limited to:
Fresenius Kabi, Baxter, Inc., B. Braun Melsungen AG, Smiths Medical, CareFusion Corporation, Caesarea Medical Electronics, and several others
This report offers the following:
An overview of the global markets for home infusion therapy
Market trends assessment for the period 2014-2022, including historical data for 2014 and 2015, as well as projections through 2022, with respective CAGRs from 2016 to 2022.
Qualitative assessment tools such as market drivers, challenges and future prospects, major commercial events, etc.
market competition scrutiny tools such as market share analysis, attractive investment propositions, and Porter’s Five Forces model
Focus on each level of market segmentation based on product approvals, launches, and current and anticipated market dynamics.
A general overview of the industry structure
Company profiles highlight key information about the major players operating in the home infusion therapy market.
Frequently Asked Questions:
The market for Home Infusion Therapy is expected to reach USD XX million Bn in 2022.
The Home Infusion Therapy market is expected to see significant CAGR growth over the coming years, at XX%.
